Author

N. Vokes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:differential expression· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Approach:statistical model· 2

Frequent Co-Authors

J. Park· 2 shared A. Bosma-Moody· 1 shared A. Cheung· 1 shared A. Duarte· 1 shared A. Flaifel· 1 shared A. G. Serrano· 1 shared A. H. Nassar· 1 shared A. Imamovic· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. Park

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities

C. A. Stewart, L. Diao, Y. Xi, R. Wang, K. Ramkumar, A. G. Serrano, B. L. Rodriguez, B. B. Morris, L. Shen, B. Zhang, Y. Yang, S. H. Hamad, R. J. Cardnell, A. Duarte, M. Sahu, , C. M. Gay

bioRxiv · Dec 19, 2023Cancer Biology

Clinical interpretation of integrative molecular profiles to guide precision cancer medicine

B. Reardon, N. D. Moore, N. Moore, E. Kofman, S. Aldubayan, A. Cheung, J. Conway, H. Elmarakeby, A. Imamovic, S. C. Kamran, T. Keenan, D. Keliher, D. J. Konieczkowski, D. Liu, K. Mouw, , E. M. Van Allen

This paper introduces MOAlmanac, a clinical interpretation algorithm that integrates genomic and transcriptional data to improve precision cancer treatment decisions by considering second-order molecular features.

bioRxiv · Sep 22, 2020Cancer Biology

Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell Carcinoma Reveals Determinants of Poor Prognosis and Response to Immune Checkpoint Inhibitors

Z. Bakouny, D. A. Braun, S. A. Shukla, W. Pan, X. Gao, Y. Hou, A. Flaifel, S. Tang, A. Bosma-Moody, M. X. He, N. Vokes, J. Nyman, W. Xie, A. H. Nassar, S. Abou Alaiwi, , T. H. Ho

This study characterizes the molecular features and immune profile of sarcomatoid and rhabdoid renal cell carcinoma, showing their responsiveness to immune checkpoint inhibitors and identifying key genetic and transcriptional determinants.

bioRxiv · May 28, 2020Cancer Biology